Evidence map›Paper›PMID 30205595›Full record

ReviewBiomedicines2018

Resveratrol: A Double-Edged Sword in Health Benefits.

Bahare Salehi, Abhay Prakash Mishra, Manisha Nigam, Bilge Sener, Mehtap Kilic, Mehdi Sharifi-Rad, Patrick Valere Tsouh Fokou, Natália Martins, Javad Sharifi-Rad

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Biomedicines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 507 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
507citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04654689 phase2completednot on this mapstarted 2021, after this paper: background citation

Impact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With G04CB02 on the Clinical Improvement of ALS Patients

TypeinterventionalSponsorFundación Universidad Católica de Valencia San Vicente MártirRan2021 to 2023Enrolled90ConditionsAmyotrophic Lateral SclerosisArmsLiposomed polyphenols resveratrol and curcumin, Placebo for liposomed resveratrol and curcumin, Isocaloric Diet, G04CB02, Placebo microcrystalline methylcellulose
NCT04867252 phase2completednot on this mapstarted 2021, after this paper: background citation

Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

TypeinterventionalSponsorKhyber Medical University PeshawarRan2021 to 2021Enrolled88ConditionsPCOSArmsResveratrol (1000mg twice a day), Myoinositol 1000mg (Twice a day), Metformin (500 mg Twice a day), Pioglitazone (15 mg Twice a day)
3 · Its place in the literature

Who cites it

507 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Molecular Targets in Modern Cosmetic Science.Molecules (Basel, Switzerland) · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

447 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bahare SalehiMedical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences, Tehran 88777539, Iran. bahar.salehi007@gmail.com.ORCID 0000-0002-6900-9797
Abhay Prakash MishraDepartment of Pharmaceutical Chemistry, H. N. B. Garhwal (A Central) University, Srinagar Garhwal 246174, Uttarakhand, India. abhaypharmachemhnbgu@gmail.com.ORCID 0000-0002-2224-0852
Manisha NigamDepartment of Biochemistry, H. N. B. Garhwal (A Central) University, Srinagar Garhwal 246174, Uttarakhand, India. m.nigam@hnbgu.ac.in.
Bilge SenerGazi University Faculty of Pharmacy Department of Pharmacognosy, Ankara 06330, Turkey. bilgesener11@gmail.com.
Mehtap KilicGazi University Faculty of Pharmacy Department of Pharmacognosy, Ankara 06330, Turkey. klcmehtap89@gmail.com.
Mehdi Sharifi-RadDepartment of Medical Parasitology, Zabol University of Medical Sciences, Zabol 61663335, Iran. mehdi_sharifirad@yahoo.com.
Patrick Valere Tsouh FokouAntimicrobial and Biocontrol Agents Unit, Department of Biochemistry, Faculty of Science, University of Yaounde 1, Ngoa Ekelle, Annex Fac. Sci, P.O. Box. 812, Yaounde-Cameroon. tsouh80@yahoo.fr.ORCID 0000-0003-3724-3527
Natália MartinsFaculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, Porto 4200-319, Portugal. ncmartins@med.up.pt.ORCID 0000-0002-5934-5201
Javad Sharifi-RadPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran 11369, Iran. javad.sharifirad@gmail.com.ORCID 0000-0002-7301-8151

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol (3,5,4'-trihydroxy-trans-stilbene) belongs to polyphenols' stilbenoids group, possessing two phenol rings linked to each other by an ethylene bridge. This natural polyphenol has been detected in more than 70 plant species, especially in grapes' skin and seeds, and was found in discrete amounts in red wines and various human foods. It is a phytoalexin that acts against pathogens, including bacteria and fungi. As a natural food ingredient, numerous studies have demonstrated that resveratrol possesses a very high antioxidant potential. Resveratrol also exhibit antitumor activity, and is considered a potential candidate for prevention and treatment of several types of cancer. Indeed, resveratrol anticancer properties have been confirmed by many in vitro and in vivo studies, which shows that resveratrol is able to inhibit all carcinogenesis stages (e.g., initiation, promotion and progression). Even more, other bioactive effects, namely as anti-inflammatory, anticarcinogenic, cardioprotective, vasorelaxant, phytoestrogenic and neuroprotective have also been reported. Nonetheless, resveratrol application is still being a major challenge for pharmaceutical industry, due to its poor solubility and bioavailability, as well as adverse effects. In this sense, this review summarized current data on resveratrol pharmacological effects.

Indexed as

anticancerantimicrobialantioxidantpharmacological activityphysiological effectsresveratrol

Identifiers

PMID30205595
PMCPMC6164842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.